The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmacokinetics Services-Global Market Insights and Sales Trends 2025
Synopsis
The global Pharmacokinetics Services market size is expected to reach US$ 884.8 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmacokinetics Services in various end use industries. The expanding demands from the Small & Medium Enterprise and Large Enterprise, are propelling Pharmacokinetics Services market. Small Molecules Pharmacokinetics Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Large Molecules (Biopharmaceuticals) Pharmacokinetics Services segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmacokinetics Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmacokinetics Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmacokinetics Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmacokinetics Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmacokinetics Services covered in this report include Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg) and Frontage Labs (US), etc.
The global Pharmacokinetics Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Global Pharmacokinetics Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics Services market, Segment by Type:
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Global Pharmacokinetics Services market, by Application
Small & Medium Enterprise
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmacokinetics Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pharmacokinetics Services market size is expected to reach US$ 884.8 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmacokinetics Services in various end use industries. The expanding demands from the Small & Medium Enterprise and Large Enterprise, are propelling Pharmacokinetics Services market. Small Molecules Pharmacokinetics Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Large Molecules (Biopharmaceuticals) Pharmacokinetics Services segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmacokinetics Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmacokinetics Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmacokinetics Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmacokinetics Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmacokinetics Services covered in this report include Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg) and Frontage Labs (US), etc.
The global Pharmacokinetics Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Global Pharmacokinetics Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics Services market, Segment by Type:
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Global Pharmacokinetics Services market, by Application
Small & Medium Enterprise
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmacokinetics Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmacokinetics Services
1.1 Pharmacokinetics Services Market Overview
1.1.1 Pharmacokinetics Services Product Scope
1.1.2 Pharmacokinetics Services Market Status and Outlook
1.2 Global Pharmacokinetics Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmacokinetics Services Market Size by Region (2018-2029)
1.4 Global Pharmacokinetics Services Historic Market Size by Region (2018-2023)
1.5 Global Pharmacokinetics Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmacokinetics Services Market Size (2018-2029)
1.6.1 North America Pharmacokinetics Services Market Size (2018-2029)
1.6.2 Europe Pharmacokinetics Services Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmacokinetics Services Market Size (2018-2029)
1.6.4 Latin America Pharmacokinetics Services Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmacokinetics Services Market Size (2018-2029)
2 Pharmacokinetics Services Market by Type
2.1 Introduction
2.1.1 Small Molecules Pharmacokinetics Services
2.1.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
2.2 Global Pharmacokinetics Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmacokinetics Services Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmacokinetics Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmacokinetics Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmacokinetics Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmacokinetics Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmacokinetics Services Revenue Breakdown by Type (2018-2029)
3 Pharmacokinetics Services Market Overview by Application
3.1 Introduction
3.1.1 Small & Medium Enterprise
3.1.2 Large Enterprise
3.2 Global Pharmacokinetics Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmacokinetics Services Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmacokinetics Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmacokinetics Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmacokinetics Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmacokinetics Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmacokinetics Services Revenue Breakdown by Application (2018-2029)
4 Pharmacokinetics Services Competition Analysis by Players
4.1 Global Pharmacokinetics Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacokinetics Services as of 2022)
4.3 Date of Key Players Enter into Pharmacokinetics Services Market
4.4 Global Top Players Pharmacokinetics Services Headquarters and Area Served
4.5 Key Players Pharmacokinetics Services Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmacokinetics Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Evotec AG (Germany)
5.1.1 Evotec AG (Germany) Profile
5.1.2 Evotec AG (Germany) Main Business
5.1.3 Evotec AG (Germany) Pharmacokinetics Services Products, Services and Solutions
5.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.1.5 Evotec AG (Germany) Recent Developments
5.2 Pacific BioLabs (US)
5.2.1 Pacific BioLabs (US) Profile
5.2.2 Pacific BioLabs (US) Main Business
5.2.3 Pacific BioLabs (US) Pharmacokinetics Services Products, Services and Solutions
5.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.2.5 Pacific BioLabs (US) Recent Developments
5.3 GVK Biosciences Private Limited (India)
5.3.1 GVK Biosciences Private Limited (India) Profile
5.3.2 GVK Biosciences Private Limited (India) Main Business
5.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Products, Services and Solutions
5.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.3.5 Shanghai Medicilon Inc. (China) Recent Developments
5.4 Shanghai Medicilon Inc. (China)
5.4.1 Shanghai Medicilon Inc. (China) Profile
5.4.2 Shanghai Medicilon Inc. (China) Main Business
5.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Products, Services and Solutions
5.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.4.5 Shanghai Medicilon Inc. (China) Recent Developments
5.5 Pharmaceutical Product Development, LLC (US)
5.5.1 Pharmaceutical Product Development, LLC (US) Profile
5.5.2 Pharmaceutical Product Development, LLC (US) Main Business
5.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Products, Services and Solutions
5.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments
5.6 Charles River Laboratories International, Inc. (US)
5.6.1 Charles River Laboratories International, Inc. (US) Profile
5.6.2 Charles River Laboratories International, Inc. (US) Main Business
5.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Products, Services and Solutions
5.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.6.5 Charles River Laboratories International, Inc. (US) Recent Developments
5.7 PAREXEL International Corporation (US)
5.7.1 PAREXEL International Corporation (US) Profile
5.7.2 PAREXEL International Corporation (US) Main Business
5.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Products, Services and Solutions
5.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.7.5 PAREXEL International Corporation (US) Recent Developments
5.8 Eurofins Scientific, Inc. (Luxembourg)
5.8.1 Eurofins Scientific, Inc. (Luxembourg) Profile
5.8.2 Eurofins Scientific, Inc. (Luxembourg) Main Business
5.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Products, Services and Solutions
5.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments
5.9 Frontage Labs (US)
5.9.1 Frontage Labs (US) Profile
5.9.2 Frontage Labs (US) Main Business
5.9.3 Frontage Labs (US) Pharmacokinetics Services Products, Services and Solutions
5.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.9.5 Frontage Labs (US) Recent Developments
5.10 SGS SA (Switzerland)
5.10.1 SGS SA (Switzerland) Profile
5.10.2 SGS SA (Switzerland) Main Business
5.10.3 SGS SA (Switzerland) Pharmacokinetics Services Products, Services and Solutions
5.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.10.5 SGS SA (Switzerland) Recent Developments
5.11 LGC Limited (UK)
5.11.1 LGC Limited (UK) Profile
5.11.2 LGC Limited (UK) Main Business
5.11.3 LGC Limited (UK) Pharmacokinetics Services Products, Services and Solutions
5.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.11.5 LGC Limited (UK) Recent Developments
5.12 Creative Bioarray (US)
5.12.1 Creative Bioarray (US) Profile
5.12.2 Creative Bioarray (US) Main Business
5.12.3 Creative Bioarray (US) Pharmacokinetics Services Products, Services and Solutions
5.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.12.5 Creative Bioarray (US) Recent Developments
5.13 Certara, L.P. (Germany)
5.13.1 Certara, L.P. (Germany) Profile
5.13.2 Certara, L.P. (Germany) Main Business
5.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Products, Services and Solutions
5.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue (US$ Million) & (2018-2023)
5.13.5 Certara, L.P. (Germany) Recent Developments
6 North America
6.1 North America Pharmacokinetics Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmacokinetics Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmacokinetics Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmacokinetics Services Market Dynamics
11.1 Pharmacokinetics Services Industry Trends
11.2 Pharmacokinetics Services Market Drivers
11.3 Pharmacokinetics Services Market Challenges
11.4 Pharmacokinetics Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
